Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

Still movingHow bills become law

Halfway — passed one chamber

One of the two groups of lawmakers voted yes. Now the other group gets to vote.

Stage 4 of 6First chamber

104
Sponsors: 0
Votes: Jul 23
Last action

Next: the other chamber takes it up — committee first, then a vote.

Official text

Take action on this

In plain words

AI summary

Written by AI from the bill text. Check the official text before relying on it.

Description

To amend the Accelerating Access to Critical Therapies for ALS Act to reauthorize the provisions of such Act through fiscal year 2031, and for other purposes.

Subjects

Health programs administration and fundingPublic-private cooperationNeurological disordersResearch administration and fundingDrug therapyNational Institutes of Health (NIH)Internet, web applications, social mediaGovernment information and archivesFood and Drug Administration (FDA)Department of Health and Human ServicesMedical researchHealth

Progress

IntroducedApr 6, 2026
Sent to committeeApr 6, 2026
Sent to committeeApr 6, 2026
Committee said yesMay 21, 2026
Committee said yesJul 9, 2026
PassedJul 22, 2026

From official state and federal legislative records. Informational only, not legal advice.